PA
AYI icon

PharVision Advisers’s Acuity Brands AYI Stock Holding History

PharVision Advisers’s Portfolio AYI Stock Details AYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-757
Closed -$261K – 703
2025
Q3 		$261K Buy
+757
New +$241K 0.15% 307
2025
Q2 		– Sell
-1,168
Closed -$308K – 281
2025
Q1 		$308K Buy
+1,168
New +$353K 0.43% 88

Other funds holding AYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PharVision Advisers's AYI Position: Q4 2025 in Review

PharVision Advisers sold out of Acuity Brands (AYI) in Q4 2025, closing a stake of 757 shares — an estimated $261K sold.

PharVision Advisers first reported a position in AYI in Q1 2025 and held it in 2 quarters. The position peaked at $308K in Q1 2025. 616 funds tracked by Wall St. Rank hold AYI as of Q4 2025.

  • PharVision Advisers reported no remaining Acuity Brands position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 757 Acuity Brands shares in Q4 2025, an estimated $261K.
  • PharVision Advisers first reported a position in Acuity Brands in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Acuity Brands position peaked at $308K in Q1 2025.
  • 616 funds tracked by Wall St. Rank held Acuity Brands as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.